首页> 外文OA文献 >Case report: Persistent strongyloidiasis complicated by recurrent meningitis in an HTLV seropositive Peruvian migrant resettled in Italy
【2h】

Case report: Persistent strongyloidiasis complicated by recurrent meningitis in an HTLV seropositive Peruvian migrant resettled in Italy

机译:病例报告:在意大利定居的HTLV血清反应阳性秘鲁移民中,持久性圆线虫病并发复发性脑膜炎

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We describe a case of persistent strongyloidiasis complicated by recurrent meningitis, in a human T cell lymphotropic virus type 1 (HTLV-1) seropositive Peruvian migrant adult resettled in Italy. He was admitted with signs and symptoms of acute bacterial meningitis, reporting four other meningitis episodes in the past 6 years, with an etiological diagnosis of Escherichia coli and Enterococcus faecium in two cases. He had been previously treated with several antihelmintic regimens not including ivermectin, without eradication of strongyloidiasis, and he had never been tested for HTLV before. During the described episode, the patient was treated for meningitis with broad-spectrum antibiotic therapy and 200 mg/kg/dose oral ivermectin once daily on day 1, 2, 15 and 16 with full recovery and no further episodes of meningitis. The presented case underlines several critical points concerning the management of poorly known neglected diseases such as strongyloidiasis and HTLV infection in low-endemic areas. Despite several admissions for meningitis and strongyloidiasis, the parasitic infection was not adequately treated and the patient was not previously tested for HTLV. The supply of ivermectin and the choice of treatment scheme was challenging since ivermectin is not approved in Italy and there are no standardized guidelines for the treatment of severe strongyloidiasis in HTLV seropositive subjects.
机译:我们描述了在人类重新定型的秘鲁人类成年人类T细胞淋巴病毒1型(HTLV-1)血清反应阳性的秘鲁移民成年人中并发复发性脑膜炎并发持续性铁线虫病的情况。他被接纳患有急性细菌性脑膜炎的体征和症状,在过去的6年中报告了另外4次脑膜炎发作,其中有2例在病原学上诊断为大肠杆菌和粪肠球菌。先前他曾接受过包括伊维菌素在内的数种抗蠕虫药治疗,未根除圆线虫病,而且他之前从未接受过HTLV的测试。在所述发作期间,患者在第1、2、15和16天每天用广谱抗生素治疗和200 mg / kg /剂量口服伊维菌素治疗脑膜炎,完全康复,无脑膜炎进一步发作。本案强调了几个关键点,这些关键点涉及在低流行地区管理鲜为人知的被忽视疾病,例如强直性线虫病和HTLV感染。尽管有数次因脑膜炎和类圆线虫病入院,但并未对寄生虫感染进行充分的治疗,并且该患者先前未接受过HTLV检测。伊维菌素的供应和治疗方案的选择具有挑战性,因为伊维菌素尚未在意大利获得批准,并且尚无用于治疗HTLV血清反应阳性患者的严重类圆线虫病的标准化指南。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号